Apogee Therapeutics Inc.

NASDAQ: APGE · Real-Time Price · USD
37.36
-0.76 (-1.99%)
At close: Aug 15, 2025, 3:59 PM
36.48
-2.36%
After-hours: Aug 15, 2025, 07:58 PM EDT

Apogee Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
141.79M 118.32M 151.89M
Short-Term Investments
378.86M 277.14M n/a
Long-Term Investments
210.42M n/a n/a
Other Long-Term Assets
498K 401K n/a
Receivables
4.7M 1.21M n/a
Inventory
n/a n/a n/a
Other Current Assets
1.74M n/a 57K
Total Current Assets
529.71M 398.41M 152.06M
Property-Plant & Equipment
13.32M 2.59M n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
224.24M 3M n/a
Total Assets
753.95M 401.4M 152.06M
Account Payables
1.07M 2.14M 418K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
3.23M 1.1M n/a
Other Current Liabilities
-1.34M -934K n/a
Total Current Liabilities
28.56M 20.56M 9.98M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
8.6M 933K n/a
Total Liabilities
37.16M 21.49M 9.98M
Total Debt
11.83M 2.03M n/a
Common Stock
1K n/a 2.25M
Retained Earnings
-305.92M -123.77M -39.78M
Comprehensive Income
915K 329K 2.14M
Shareholders Equity
716.79M 379.91M 142.07M
Total Investments
589.28M 277.14M n/a